ATE130188T1 - Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe. - Google Patents

Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.

Info

Publication number
ATE130188T1
ATE130188T1 AT91920733T AT91920733T ATE130188T1 AT E130188 T1 ATE130188 T1 AT E130188T1 AT 91920733 T AT91920733 T AT 91920733T AT 91920733 T AT91920733 T AT 91920733T AT E130188 T1 ATE130188 T1 AT E130188T1
Authority
AT
Austria
Prior art keywords
producing
dosage unit
solid dosage
delayed release
dosage units
Prior art date
Application number
AT91920733T
Other languages
English (en)
Inventor
Per Johan Gunnar Lundberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Application granted granted Critical
Publication of ATE130188T1 publication Critical patent/ATE130188T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Control Of Vending Devices And Auxiliary Devices For Vending Devices (AREA)
  • Compositions Of Oxide Ceramics (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT91920733T 1990-12-07 1991-12-03 Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe. ATE130188T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003904A SE9003904D0 (sv) 1990-12-07 1990-12-07 Method for the manufacture of a pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
ATE130188T1 true ATE130188T1 (de) 1995-12-15

Family

ID=20381123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91920733T ATE130188T1 (de) 1990-12-07 1991-12-03 Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.

Country Status (20)

Country Link
US (1) US5419918A (de)
EP (1) EP0560822B1 (de)
JP (1) JP3239319B2 (de)
AT (1) ATE130188T1 (de)
AU (1) AU659114B2 (de)
CA (1) CA2097175A1 (de)
DE (1) DE69114721T2 (de)
DK (1) DK0560822T3 (de)
ES (1) ES2079689T3 (de)
FI (1) FI932552A0 (de)
GR (1) GR3018685T3 (de)
HU (1) HUT64212A (de)
IE (1) IE914229A1 (de)
IS (1) IS3789A7 (de)
NO (1) NO932054D0 (de)
PL (1) PL168605B1 (de)
PT (1) PT99721A (de)
SE (1) SE9003904D0 (de)
WO (1) WO1992010169A1 (de)
YU (1) YU182091A (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
RO112991B1 (ro) * 1992-09-18 1998-03-30 Yamanouchi Pharma Co Ltd Preparat tip hidrogel, cu eliberare sustinuta
ES2059260B1 (es) * 1992-10-06 1995-04-16 Espanola Prod Quimicos Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
JP2000034224A (ja) * 1998-05-11 2000-02-02 Freunt Ind Co Ltd 徐放性錠剤、その添加剤組成物及びそれらの製造方法
US6368625B1 (en) 1998-08-12 2002-04-09 Cima Labs Inc. Orally disintegrable tablet forming a viscous slurry
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2003011256A1 (en) * 2001-07-30 2003-02-13 Sun Pharmaceutical Industries Limited Oral controlled release pharmaceutical composition of a prokinetic agent
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20040185093A1 (en) * 2003-03-18 2004-09-23 Szymczak Christopher E. Compositions containing sucralose
US20060062811A1 (en) * 2004-09-21 2006-03-23 Szymczak Christopher E Medicinal cooling emulsions
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
KR102271048B1 (ko) * 2013-04-16 2021-06-30 머레이 앤 풀 엔터프라이지즈, 리미티드 콜히친의 서방형 제형 및 이의 이용 방법
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
CA1247852A (en) * 1983-12-20 1989-01-03 Akihiko Nomura Process for preventing agglomeration of powders
US4795327A (en) * 1984-03-26 1989-01-03 Forest Laboratories, Inc. Controlled release solid drug dosage forms based on mixtures of water soluble nonionic cellulose ethers and anionic surfactants
WO1988004922A1 (fr) * 1986-12-25 1988-07-14 Teysan Pharmaceuticals Co., Ltd. Granule a dissolution lente et granule composite a effet persistant prepare a partir du premier granule
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
DE69114721T2 (de) 1996-04-18
SE9003904D0 (sv) 1990-12-07
NO932054L (no) 1993-06-04
US5419918A (en) 1995-05-30
DE69114721D1 (de) 1995-12-21
DK0560822T3 (da) 1996-03-11
WO1992010169A1 (en) 1992-06-25
HU9301672D0 (en) 1993-09-28
AU659114B2 (en) 1995-05-11
IS3789A7 (is) 1992-06-08
EP0560822A1 (de) 1993-09-22
CA2097175A1 (en) 1992-06-08
YU182091A (sh) 1994-04-05
NO932054D0 (no) 1993-06-04
FI932552A7 (fi) 1993-06-04
JPH06503310A (ja) 1994-04-14
PT99721A (pt) 1993-04-30
GR3018685T3 (en) 1996-04-30
PL168605B1 (pl) 1996-03-29
ES2079689T3 (es) 1996-01-16
FI932552L (fi) 1993-06-04
EP0560822B1 (de) 1995-11-15
IE914229A1 (en) 1992-06-17
PL299376A1 (en) 1994-03-07
HUT64212A (en) 1993-12-28
JP3239319B2 (ja) 2001-12-17
FI932552A0 (fi) 1993-06-04
AU8930991A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
ATE130188T1 (de) Verfahren zur herstellung einer festen dosierungseinheit zur verzögerten freigabe.
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE69131775D1 (de) Verfahren zur Herstellung wasserlöslicher Camptothecinanaloge, sowie die Verbindungen 10-Hydroxy-11-C(1-6)-alkoxycamptothecin
ATE151764T1 (de) Neue benzopyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltenden zubereitungen
EP1095656A3 (de) Pharmazeutische Zubereitung mit dem Cholinesterase-Hemmstoff Galanthamin
ATA151687A (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
DE59908764D1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
DE3575927D1 (de) Purinderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
IS1664B (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandiog kvalastillandi áhrif
AT381639B (de) Verfahren zur herstellung pharmazeutischer tabletten mit verzoegerter wirkstofffreigabe
ATE7228T1 (de) Imidazolinderivat, dessen salze, verfahren zur herstellung und dessen pharmazeutische zusammensetzungen.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
DE3682811D1 (de) Pharmazeutische zusammensetzung zur heilung und verhuetung kardiovaskularer krankheiten und verfahren zu ihrer herstellung.
RU92004530A (ru) Производные гуанидиналкил-1,1-бис-фосфоновой кислоты, способ их получения, лекарственные средства и способ их получения
DE68917937D1 (de) Verbindungen mit magensäureinhibitorwirkung und verfahren zur herstellung.
ATE45156T1 (de) Substituierte benzimidazole, verfahren zu ihrer herstellung und ihre anwendung zur hemmung der magensaeuresekretion.
DE69104220D1 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE69614096D1 (de) Verfahren zur herstellung einer festen arzneimitteldosierungsform
ATE307823T1 (de) 17a-fluoralkyl-11beta-benzaldoxim-steroide, verfahren zu deren herstellung, diese steroide enthaltende pharmazeutische präparate sowie deren verwendung zur herstellung von arzneimitteln
EP0173950A3 (de) Neuer alpha-Glukosidase Inhibitor, Verfahren zur seiner Herstellung, seine Verwendung und pharmazeutische Präparate
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE69532533D1 (de) Verfahren zur herstellung von ranitidin
DE69514512D1 (de) Verfahren zur herstellung von benzopyranderivaten
ATE11530T1 (de) P-chlorophenoxyessigsaeure-derivat, verfahren zu dessen herstellung und pharmazeutische zusammenstellung.
DE68907900D1 (de) Verfahren zur herstellung von oxyessigsaeure/hydroxyethyletherverbindung.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time